0000000000625320

AUTHOR

Marzia Mare

showing 4 related works from this author

Targeting Phosphatases and Kinases: How to Checkmate Cancer

2021

Metastatic disease represents the major cause of death in oncologic patients worldwide. Accumulating evidence have highlighted the relevance of a small population of cancer cells, named cancer stem cells (CSCs), in the resistance to therapies, as well as cancer recurrence and metastasis. Standard anti-cancer treatments are not always conclusively curative, posing an urgent need to discover new targets for an effective therapy. Kinases and phosphatases are implicated in many cellular processes, such as proliferation, differentiation and oncogenic transformation. These proteins are crucial regulators of intracellular signaling pathways mediating multiple cellular activities. Therefore, altera…

cancer stem cellkinaseQH301-705.5PopulationPhosphataseDiseaseReviewBiologyMetastasisphosphatasecancer stem cell kinase phosphatase phosphatase and kinase inhibitors targeted therapiesCell and Developmental BiologyCancer stem cellmedicineBiology (General)educationphosphatase and kinase inhibitorseducation.field_of_studyKinaseCancerCell Biologymedicine.diseasetargeted therapiesCancer cellCancer researchDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct

Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?

2020

Abstract Aim This paper aims to analyze the usefulness of the G8 geriatric oncology questionnaire in patients with advanced/metastatic pancreatic adenocarcinoma (aPAC) and its possible association with different clinical outcomes. Methods Patients age > 70 years were screened with the G8 tool and treated with intravenous nab-paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2 for 3 consecutive weeks followed by one-week rest as prescribed after clinical evaluation by treating oncologists. Patient’s charts were evaluated for type and severity of toxicity, 2 cycle rate of completion, discontinuation rate, delays, dose reductions, and other outcomes response rates, progression-free, and overall su…

medicine.medical_specialtyAdenocarcinoma03 medical and health sciences0302 clinical medicineInternal medicinePancreatic cancerAntineoplastic Combined Chemotherapy ProtocolsmedicineHumans030212 general & internal medicineGeriatric AssessmentAgedResponse rate (survey)business.industryGeriatric assessmentGemcitabine Maintenance Nab-paclitaxel Older adults Pancreatic cancerMetastatic Pancreatic Adenocarcinomamedicine.diseaseGemcitabineDiscontinuationPancreatic NeoplasmsOncologyGeriatric oncology030220 oncology & carcinogenesisToxicityGeriatrics and Gerontologybusinessmedicine.drug
researchProduct

Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review

2021

Background: Rectal cancer (RC) is one of the most commonly diagnosed and particularly challenging tumours to treat due to its location in the pelvis and close proximity to critical genitourinary organs. Radiotherapy (RT) is recognised as a key component of therapeutic strategy to treat RC, promoting the downsizing and downstaging of large RCs in neoadjuvant settings, although its therapeutic effect is limited due to radioresistance. Evidence from experimental and clinical studies indicates that the likelihood of achieving local tumour control by RT depends on the complete eradication of cancer stem cells (CSC), a minority subset of tumour cells with stemness properties. Methods: A systemati…

OncologyNeo-adjuvant radiotherapymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentReviewQH426-470RadiosensitivityCancer stem cellRadioresistanceInternal medicineBiomarkers TumorGeneticsmedicineHumansGenetics (clinical)Rectal cancer (RC)biologyRectal NeoplasmsCancer stem cellsGenitourinary systembusiness.industryCD44Therapeutic effectmedicine.diseaseOrganoidsRadiation therapyTreatment OutcomeSystematic reviewIn vitro radiotherapyNeoplastic Stem Cellsbiology.proteinbusinessGenes
researchProduct

Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery.

2021

Obesity is a strong risk factor for cancer progression, posing obesity-related cancer as one of the leading causes of death. Nevertheless, the molecular mechanisms that endow cancer cells with metastatic properties in patients affected by obesity remain unexplored. Here, we show that IL-6 and HGF, secreted by tumor neighboring visceral adipose stromal cells (V-ASCs), expand the metastatic colorectal (CR) cancer cell compartment (CD44v6 + ), which in turn secretes neurotrophins such as NGF and NT-3, and recruits adipose stem cells within tumor mass. Visceral adipose-derived factors promote vasculogenesis and the onset of metastatic dissemination by activation of STAT3, which inhibits miR-200…

MaleCancer microenvironmentobesityStromal cellColorectal cancerScienceSettore MED/50 - Scienze Tecniche Mediche ApplicateGeneral Physics and AstronomyAdipose tissueMice SCIDSCIDmetastasis.General Biochemistry Genetics and Molecular BiologyArticleMiceVasculogenesisSettore MED/04 - PATOLOGIA GENERALEmedicineAnimalsHumansNeoplasm MetastasisStem Cell NicheZinc Finger E-box Binding Homeobox 2Tumor microenvironmentMultidisciplinarybusiness.industryHepatocyte Growth FactorInterleukin-6Stem CellsQadipose stromal cellCancerCD44v6General Chemistrymedicine.diseaseCellular ReprogrammingColorectal cancerMicroRNAsAdipose TissueCancer cellColonic NeoplasmsCancer researchNeoplastic Stem Cellsconsensus molecular subtypeStem cellSettore MED/46 - Scienze Tecniche Di Medicina Di LaboratoriobusinessNature communications
researchProduct